Literature DB >> 14465561

Studies on a new intramuscular haematinic, iron-sorbitol.

S LINDVALL, N S ANDERSSON.   

Abstract

A new iron preparation for intramuscular use is described. It contains a complex of iron, sorbitol and citric acid. Its properties in comparison with several other complexes, particularly iron-dextran, have been studied. The preparation is stable in serum, is hypertonic, does not produce haemolysis, and affects coagulation only at very high concentrations, such as are reached only in vitro. Absorption from muscle takes place very rapidly; two-thirds of the iron is removed within 3 hr, and there is a very rapid increase in the serum-iron concentration. In experimental animals, the maximum level is reached after about 20 min and in man after about 2 hr. Disappearance from the serum takes place rapidly. The preparation contains a small amount of a fraction which reacts with transferrin and is dialysable. In man, about 30% of the total dose of iron is excreted through the kidneys during the first 24 hr after injection, the greater part of the excretion taking place during the first few hours.

Entities:  

Keywords:  IRON/pharmacology; SORBITOL/pharmacology

Mesh:

Substances:

Year:  1961        PMID: 14465561      PMCID: PMC1482102          DOI: 10.1111/j.1476-5381.1961.tb01122.x

Source DB:  PubMed          Journal:  Br J Pharmacol Chemother        ISSN: 0366-0826


  15 in total

1.  Mechanism of absorption of two intramuscular iron preparation.

Authors:  P O SVARD; S LINDVALL
Journal:  J Pharm Pharmacol       Date:  1961-11       Impact factor: 3.765

2.  Studies on iron-dextran complex.

Authors:  T KARLEFORS; A NORDEN
Journal:  Acta Med Scand Suppl       Date:  1958

3.  [Intramuscular iron treatment].

Authors:  N S ANDERSSON
Journal:  Sven Lakartidn       Date:  1956-01-05

4.  Studies on in vivo stability of an iron chelate.

Authors:  M J SEVEN; R E PETERSON
Journal:  Proc Soc Exp Biol Med       Date:  1958-02

5.  The pharmacology of an iron-dextran intramuscular haematinic.

Authors:  L E MARTIN; C M BATES; C R BERESFORD; J D DONALDSON; F F MCDONALD; D DUNLOP; P SHEARD; E LONDON; G D TWIGG
Journal:  Br J Pharmacol Chemother       Date:  1955-09

6.  Intramuscular iron therapy in iron-deficiency anaemia.

Authors:  I M BAIRD; D A PODMORE
Journal:  Lancet       Date:  1954-11-06       Impact factor: 79.321

7.  Anaemia of pregnancy treated with intramuscular iron.

Authors:  J M SCOTT; A D T GOVAN
Journal:  Br Med J       Date:  1954-11-27

8.  The mechanisms of toxicity of some iron preparations.

Authors:  J A NISSIM
Journal:  Br J Pharmacol Chemother       Date:  1954-03

9.  Plasma iron levels and urinary iron excretion after the intravenous administration of different iron preparations.

Authors:  J A NISSIM
Journal:  Br J Pharmacol Chemother       Date:  1953-12

10.  CHEMICAL, CLINICAL, AND IMMUNOLOGICAL STUDIES ON THE PRODUCTS OF HUMAN PLASMA FRACTIONATION. XXXIX. THE ANEMIA OF INFECTION. STUDIES ON THE IRON-BINDING CAPACITY OF SERUM.

Authors:  G E Cartwright; M M Wintrobe
Journal:  J Clin Invest       Date:  1949-01       Impact factor: 14.808

View more
  9 in total

1.  THE FATE OF IRON-SORBITOL IN RAT STRIATED MUSCLE. AN ELECTRON MICROSCOPIC STUDY.

Authors:  M LUNDIN; U SCHELIN
Journal:  Z Zellforsch Mikrosk Anat       Date:  1964-08-18

2.  Haematuria following "Jectofer".

Authors:  A G CHAPPELL
Journal:  Br Med J       Date:  1963-03-16

3.  Metabolism of 59Fe-sorbitol complex in man.

Authors:  G WETHERLEY-MEIN; J G BUCHANAN; U H GLASS; L C PEARCE
Journal:  Br Med J       Date:  1962-06-30

4.  [Physico-chemical studies on the ferritin and protein spectrum in a case of pulmonary hemosiderosis with glomerulonephritis. (Goodpasture's syndrome)].

Authors:  H J Bungert; H Leonhardt; H N Macha
Journal:  Klin Wochenschr       Date:  1971-12-01

5.  Experimental hepatic iron overload in the baboon: results of a two-year study. Evolution of biological and morphologic hepatic parameters of iron overload.

Authors:  P Brissot; J P Campion; A Guillouzo; H Allain; M Messner; M Simon; B Ferrand; M Bourel
Journal:  Dig Dis Sci       Date:  1983-07       Impact factor: 3.199

6.  THE DISTRIBUTION OF PARENTERAL IRON HAEMATINICS IN NONPREGNANT, PREGNANT AND LACTATING RATS.

Authors:  K G HOEGBERG; S LINDVALL
Journal:  Br J Pharmacol Chemother       Date:  1964-04

7.  In vivo behaviour of low molecular weight iron complexes.

Authors:  L J Anghileri; A Cordova Martinez; P Maincent; J Robert
Journal:  Eur J Drug Metab Pharmacokinet       Date:  1991 Jul-Sep       Impact factor: 2.441

8.  Studies on a new intramuscular haematinic for piglet anaemia.

Authors:  K G Högberg; S Lindvali; K Orth; B Thafvelin; K Uthne
Journal:  Acta Vet Scand       Date:  1968       Impact factor: 1.695

9.  Test of an iron sorbitol-citric acid complex (Jectofer) for carcinogenicity in rats.

Authors:  F J Roe; A Haddow
Journal:  Br J Cancer       Date:  1965-12       Impact factor: 7.640

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.